The authors present fragment screening data obtained using a label-free parallel analysis approach where the binding of fragment library compounds to 4 different target proteins can be screened simultaneously using surface plasmon resonance detection. They suggest this method as a first step in fragment screening to identify and select binders, reducing the demanding requirements on subsequent X-ray or nuclear magnetic resonance studies, and as a valuable "clean-up" tool to eliminate unwanted promiscuous binders from libraries. A small directed fragment library of known thrombin binders and a general 500-compound fragment library were used in this study. Thrombin, blocked thrombin, carbonic anhydrase, and glutathione-Stransferase were immobilized on the sensor chip surface, and the direct binding of the fragments was studied in real time. Only 12 μg of each protein is needed for screening of a 3000-compound fragment library. For screening, a binding site-blocked target as reference facilitates the identification of binding site-selective hits and the signals from other reference proteins for the elimination of false positives. The scope and limitations of this screening approach are discussed for both target-directed and general fragment libraries. (Journal of Biomolecular
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D
URING THE PAST DECADES, the identification of hits during early drug discovery has relied heavily on high-throughput screening (HTS). Although HTS has been relatively successful, there is a need for alternative approaches to spread risks and to explore novel areas of the medicinal chemistry space. 1 One obvious risk with HTS is the use of compound collections, which entails a historical bias regarding the compound structures and molecular weights. Unless the compound bank is stratified to exclude unwanted compounds, such as those of high molecular weight, or unwanted fragments (e.g., anilinic moieties), it has been found that hits identified using HTS have a tendency to exhibit unwanted properties. 2 This results in unfavorable starting points for further optimization, with ensuing risks for Lipinski's rule-of-5 violations. 3 Other issues with HTS are the prevalence of false positives and negatives. 4 Structure-based biophysical screening (e.g., by nuclear magnetic resonance [NMR] or crystallization and X-ray) based on fragment libraries 5, 6 is a relatively new lead identification approach within the drug discovery sphere. Likely advantages include the possibility for creative novelty in lead structures and the immense potential for increased structural diversity within the medicinal chemistry space, 7 with consequent applicability to rational molecular design approaches. 8 Importantly, lead series discovery with lower molecular weight allows the drug designer to add, rather than exchange, chemical functionality because fragment hits typically are found in the molecular weight range of 100 to 300 Da. Such hits suffer from relatively weak affinities (30 μm → mM) to the target protein, 9, 10 however, necessitating new quality assessments to navigate among the identified hits. 11 The general idea is that even if the fragments have a low affinity, they might have a high efficiency of binding per atom and therefore can serve as reasonable starting points for further optimization. 12 Fragment libraries are often small, containing from 500 to a few thousand compounds, but the size of these libraries is growing. Fragment screening methods mainly have been based on NMR and X-ray, which suffer from low throughput and relatively high target protein cost. In X-ray assays, a cocktail of fragments is soaked into the crystals, and fragment binding is measured using 3D X-ray crystal structures. The advantages of X-ray and NMR are that they give information on the binding motif and binding geometry, which allows structure-based design of new binders. However, those methods suffer from high protein consumption (e.g., an NMR screen of 2000 compounds typically uses 200-600 mg of protein), crystallizability of proteins, and low throughput. Protein breakdown during soaking experiments can also be limiting for this approach (M. Hennig, personal communication, [*YEAR?*]). Other fragment screening methods are based on high concentration screening using ordinary HTS assays. The major problems with such HTS approaches include the large number of false positives and cytotoxic effects seen in cellular assays, as well as a dependence on high ligand water solubility.
Label-free, biosensor-based primary screening of fragment libraries is attractive due to the relative high throughput now available and low target protein consumption in relation to other biophysical screening methods. The low target consumption relates to the immobilization of the proteins onto a chip surface, allowing up to thousands of compounds to be sequentially studied using the same surface before target protein renewal is required. Huber and colleagues, in a series of reports, 13, 14 have based their fragment screening strategy on the use of the differential signals from fragments interacting simultaneously with the wild-type target protein and binding site-mutated or covalently blocked target. This rapidly eliminates false positives and binders to sites other than the active site, thereby identifying compounds with the desired selectivity.
In this article, we present the development of a rapid biophysical screening method based on a surface plasmon resonance (SPR) instrument with parallel analysis capabilities, Biacore A100. We initially investigated the theoretical limit of detection of fragment compounds at different concentrations for various target sizes and immobilization levels. Subsequently, promiscuous binders were identified and eliminated. Screens were performed and affinities for thrombin compared using either blocked target or unmodified reference surface. The discussion and conclusions are mainly based on thrombin binders identified from a directed amidine library and a general, commercially available 500-compound fragment library.
MATERIALS AND METHODS
Fragment libraries
The amidine library was a collection from the AstraZenaca compound collection, and the 500-compound general fragment library was purchased from Maybridge (Geel, Belgium). Structural scaffolds included in the directed amidine library are shown in Figure 1a , and molecular weight distribution and the number of nonhydrogen atoms are shown for both libraries in Figure 1b -e.
SPR methodology
All experiments were performed with a Biacore A100 instrument using Series S sensor Chip CM5 (Biacore AB, Uppsala, Sweden). As running buffer, a 10-mM phosphate buffer with 137 mM NaCl, 2.7 mM KCl, 0.05% surfactant P20 (Biacore AB), and 5% DMSO (Riedel de-Haën, Seelze, Germany) was used.
The proteins were amine coupled (EDC/NHS, amine coupling kit, Biacore AB) to the sensor chip using a 10-mM NaAc (pH 5.0) as a coupling buffer (Biacore AB). Typical immobilization levels were 5000 to 6000 RU (resonance units) for thrombin and blocked thrombin, 8000 RU for carbonic anhydrase (CA), and 14,000 RU for glutathione-S-transferase (GST).
GST, CA, thrombin, and thrombin-diisopropylfluorophosphate (DFP) were immobilized on spots 1, 2, 4, and 5, respectively, of all 4 flow cells. Phosphate-buffered saline (PBS) buffer with 0.05% surfactant P20 (Biacore AB) and 5% DMSO was used as the running buffer. Routinely, the following concentrations (μg/mL) and injection times (min) were used: GST, 10 μg/mL, 5 min; CA, 100 μg/mL, 15 min; thrombin, 20 μg/mL, 5 min; and thrombin-DFP, 20 μg/mL, 7 min.
Compounds deemed to be relevant for thrombin binding were provided by AstraZeneca (R&D, Mölndal, Sweden), and all samples were dissolved in pure DMSO to form 10-or 100-mM stock solutions. Samples of 10 μL were diluted to 10 mM in Eppendorf vials. All samples were stored at +8 °C.
The Maybridge library was run in a 384-well plate format. The substances were initially dissolved in DMSO to 100 mM in glass vials. Aliquots were dispensed to mother plates and further diluted with DMSO to 50 mM. Concentration series (0.9, 0.45, 0.225, 0.1125, and 0.05625 mM) in the running buffer (see above) were prepared and dispensed using a MultiPROBE II automated liquid-handling system (Packard, Waltham, MA), and the plates were immediately sealed. It is important to use parallel pipetting to avoid long evaporation times, which may change the DMSO concentration and, hence, the bulk refractive index of the samples.
The flow rate was 30 μl/min. Test substances and positive controls were injected in a cycle with a contact time of 30 s and dissociation time of 30 s, followed by an extra wash of the flow system with 50% DMSO.
The Z′ value was calculated according to
Theoretical aspects of fragment binding
Compounds in a fragment library can generally be expected to have a low affinity for their target. Experimental data further demonstrate that steady-state binding can be expected for most compounds. In this section, we describe how we can estimate the affinity window for different screening scenarios. By assuming that fragments bind to their target in a 1:1 fashion, the SPR response values can be calculated from the following equilibrium equation:
In this equation, R eq is the equilibrium response, C is the concentration of the fragment compound, R max is the saturation response, and KD is the affinity of the fragment for the target molecule. The fragment concentration is now expressed as a fraction, f, of the KD concentration:
Because SPR response values can be correlated to mass, the saturation response R max can be expressed in terms of the molecular weights of target and compound and the target immobilization level:
Note that the R max value is adjusted with a target activity factor because not all target molecules can be expected to be in active form. For simplicity, the specific response values from target protein and fragment compound are also assumed to be identical.
By combining equations (1) and (2) and solving for f,
The smallest R eq value that can be reliably measured, R eq-cutoff , can be identified from average response values and standard deviations obtained with negative controls.
R max levels for different target and compound molecular weights and target activities are now calculated from equation (3) . The f values corresponding to these R max values and R eq-cutoff are calculated from equation (4) . By using actual or hypothetical screen concentrations, the affinity cutoff can be obtained by insertion of this f value in equation (2) .
RESULTS
Theoretical aspects on identification of fragment binding
In Biacore instruments, the fragment binding to target proteins is measured in real time as a change in mass in a hydrogel close to the surface of the chip. The signal increases with the molecular weight of the fragment and the number of available binding sites, which varies with the size and immobilization level of the target protein. Table 1 gives an overview of the levels of immobilization that can normally be obtained by capture or covalent coupling procedures. To obtain an understanding of the theoretical scope and limitations of running fragment screening with Biacore, we performed a few simple calculations using different target molecular weights and immobilization levels. We used a fragment size of 150 Da, which should be very close to the low end of a typical general fragment library. The detection cutoff of 5 RU is based on an average typical negative control signal plus 3 standard deviations. The data in Table 2 for a 150-Da fragment analyzed at different concentrations suggest that a millimolar binding of a fragment will be possible to identify for most protein targets for soluble compounds. For affinities of 100 μM or lower, all target sizes could be used. A 20-kDa target had a KD cutoff of 300, 600, and 800 μM at screening concentrations of 100, 200, and 300 μM, respectively. At a screening concentration of 500 μM and target molecular weights below 60 kDa, fragments with millimolar affinities could be detected. For targets with high molecular weights (>60 kDa), high immobilization levels and screening concentrations were needed to identify binders.
Testing of possible screening concentration range
Screens of an amidine library were initially performed and compared at a concentration of 100 and 200 μM. The Z′ value was 0.85 for the positive control in the 200-μM screen. A typical fragment interaction was indicated by rapid on and off rates (Fig. 3a) . At high concentration, the issues related to precipitation, micelle formation, or nonspecific binding to the surface increased. As shown in Figure 3a , such problems were often identified by inspection of the sensorgrams (real-time plot of binding response against time), and the highest concentration 
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had to be omitted from affinity calculations on occasions (Fig.  3b) . The sensorgrams shown in Figure 3 indicate typical warning signals, such as rapid jumps (microprecipitates), slow upward drift during injection (secondary slow interactions and/or micelle binding), elevated stable baseline levels (microprecipitates), and slow non-1:1 dissociation after injection. The number of such issues identified was 8 at 100 μM and 14 at 200 μM from one 96-well plate of amidine fragments.
Combining sensorgram signals from parallel analyses
The results from fragment identification and improved elimination of unwanted binders using the signals collected simultaneously from the 4 immobilized proteins are depicted in Figure 4 . For illustration, 17 fragments, screened at 200 μM, were selected, with diverse binding properties. The subtraction of the blocked thrombin signal from the wild type identifies fragments binding to the designated binding site (Fig. 4a) . Of the 7 first compounds (1-7), 5 showed signals above the hit identification threshold of 4 RU. After subtraction of the signal from the blocked thrombin, these compounds were judged not to be inhibitors. For the remaining fragments 8 to 17, 3 sensorgrams indicated compounds with strong general protein-binding tendencies (8, 12, 13) , as identified by the CA and GST signals (Fig. 4b) . This illustrated the strength of combined information from several target protein spots because a subgroup of 7 compounds with specific binding to the designated protein cavity could be defined. This saves time and effort for the experimentalist without compromising quality.
Screening affinity from concentration series
Two different concentration intervals were initially used for screening of the affinities of the 2 libraries. The directed amidine library was analyzed at 3 to 200 μM, whereas the general Maybridge fragment library was screened at 56 to 900 μM. A second concentration series (0.1 nM to 10 μM) was run for those fragments from the directed amidine library that saturated the binding site at the lowest concentration because low-end data for K D were otherwise lacking for these experiments. The correlation between enzyme inhibition pIC 50 and pK D was R = 0.80 (n = 17) for the amidine library. To test if it was possible to measure affinities using a blank dextran surface as reference for thrombin, we compared data with blocked thrombin referenced data (Fig. 5) . The correlation was excellent for the high-affinity fragments (K D < 10 μM, R 2 = 0.93) and very good for the entire affinity range (R 2 = 0.86). However, the dextran surface referenced data were biased toward lower affinities.
Screening of a general fragment library
The Maybridge library was first screened at 900 μM to identify problematic fragments. An overlaid baseline shift versus cycle number plot for all spots was instrumental for identifying fragments showing slow dissociation with a binding stoichiometry larger than 1:1 and/or promiscuous binding (e.g., stable binding to several proteins or protein domains; see Fig. 6a ).
Typical selective fragment binding signals were in the range of 5 to 30 RU, whereas many of the promiscuous binders had signals in excess of 10 times these expected levels, most probably due to formation of micelles and nonspecific interactions. The binding signal after such interaction with the surface varied from totally nonselective binding (i.e., to all 4 proteins and the dextran reference spot) to partial selectivity indicated by binding mainly to CA/GST or thrombin-blocked thrombin spots. Micelle-forming fragments also frequently give false-positive signals in other assays, leading to limited value as a drug discovery tool and should be omitted from fragment libraries. Fortunately, these compounds do not influence the binding of the positive control compounds (i.e., they do not produce false negatives in the following cycles of fragment injections). The main negative effect of these compounds was their occasionally prolonged dissociation from the surface leading to baseline drift and an increased noise level in the assay.
These compounds are not identified in typical solubility assays because they are semisoluble and form molecular clusters. The method presented here eliminates false positives, which often are caused by nonspecific binding of micelles to the target in activity-based screening assays. Screening quality can, therefore, be significantly improved by removing these compounds from the library. Reactive compounds that irreversibly block the binding site of the target are identified routinely using repeated injection of positive controls during the screen. If this happens, the compound is eliminated, and the screen is then rerun for the remaining compounds.
After discarding the 18 promiscuous binders, the remaining compounds in the fragment library were screened using a 6-point 0-to 900-μM concentration series (Fig. 6b) . In total, 26 fragments had 1 or 2 concentrations (at 450 and 900 μM) that provided signals above 5 RU, which was used as a hit identification threshold (average negative + 3⋅SD). This indicated that general nondirected fragment libraries should initially be screened at such high concentrations. The use of a limited number of concentrations for screening of each fragment increased the quality in the detection of binders. For example, there were several compounds (see Fig. 6b ) where only the highest concentration gave a signal above the threshold, but at the same time, lower concentrations seemed to follow a dosedependent pattern that supported their inclusion as hits. We also calculated a first set of affinity estimates for the binders and found compounds with affinities in the 0.5-to 2.5-mM ranges. The number of concentrations used was, however, insufficient for generating high-quality affinity values. K D value calculations were also hampered by low affinities (e.g., only 900 μM gave a detectable signal).
DISCUSSION
The sensitivity required for detecting fragment binding is dependent on the immobilization level, the size of the target molecule (number of available binding sites per surface area), and the screening concentration used. The immobilization level is mainly dependent on whether a capture or covalent coupling immobilization method is used. Covalent coupling can often result in higher immobilization levels than capture techniques. The theoretical calculations (see Table 2 ) showed that for typical target sizes, all immobilization chemistries are useful for fragment screening. For larger targets, however, the detection of fragment binding is only possible if direct immobilization or histidine capture is used, and in general, capturing methods are not useful for targets larger than ~60 kDa.
The detection limit of binding is also related to the solubility of the fragments, which becomes an issue even at the sample preparation stage. Twenty of the initial 500 fragments in the Maybridge library could not be dissolved at 100 mM in DMSO. Of the remaining 480 compounds, 18 fragments showed stable promiscuous >1:1 binding behavior to several proteins. However, such nonspecific binding behavior, including a slow dissociation rate, does not influence the interaction potential of the binding site of the target because changes in stable signals from positive controls were not observed. We introduced a library cleaning step to eliminate these compounds, which significantly decreased the variability of negative control responses. The remaining 462 fragments were screened using a 6-point dose-response screen. For this small library, the screening at multiple concentrations was appropriate and also increased the validity of the identified hits by showing a systematic, dose-responsive increase in signal. This does not significantly increase the consumption of samples because the concentration series were prepared in 384 plates. Higher quality data were therefore achieved with only a minor increase in sample consumption, and in a reasonably short time (462 fragments in 2 days), while also producing important information such as preliminary affinity estimates and validity of binders. The use of the concentration series is in line with the concept of "quantitative HTS screening," which was recently proposed as a high-quality screening strategy. 4 If larger libraries are used, then single-concentration assays are more suitable for the primary screen, and with the present method,~1400 compounds can be screened in 24 h.
The selection of screening concentrations should be balanced between the number of likely false positives and negatives. A high screening concentration minimizes the number of false negatives but at the same time increases assay difficulties caused by precipitation, micelle formation, and nonspecific binding. We identified a significant increase in the number of such issues when the concentration was increased from 100 to 200 μM for the directed amidine library. For the Maybridge library, we used an initial library cleaning step in which promiscuous binders were eliminated. At high concentrations, secondary interactions also became prevalent, which might have influenced affinity measurements. Fragment binding to off-target sites, however, can easily be identified by using binding site blockers or mutated target protein as a reference or by performing competition experiments (data not shown). For the 2 libraries used in this study, 100 to 200 μM was judged as appropriate for the directed library and the 0.5 to 1 mM range for the general fragment library. The high concentrations in the latter case are needed for detecting fragments comprising millimolar affinity. Screening at these high concentrations increases the need for performing a library cleaning step to eliminate promiscuous binders and the use of in-line reference proteins for hit validation. The strategy of using binding site blocked or mutated targets as reference protein for the identification of binding site-selective compounds was initially implemented in label-free screening at Hoffman La Roche. 13, 14 The affinities measured using a blocked thrombin or a dextran surface as a reference for affinity measurements of the fragments were compared in the benzamidine library. The correlation was excellent for the high-affinity fragments and reasonable for the weaker binders, which indicated that for directed libraries, the use of impaired proteins as reference is not mandatory. In this article, we also introduced the use of other secondary proteins for the identification of general protein binders. The combined reference protein strategy worked nicely in the library cleaning step and helps significantly in focusing on the identification of bona fide selective binders.
CONCLUSIONS
The label-free assay design presented here, based on a parallel interaction array system, is highly suitable for primary screening of fragment libraries. It provides simultaneous information on yes/no binding, binding stoichiometry, binding site selectivity, and affinity estimates, using only minute amounts of protein (e.g., screening ~3000 fragments against thrombin in 2 days consumed just 12 μg of the protein). The method can also be used for the elimination of promiscuous compounds from fragment libraries. We suggest that this prescreening approach, in which only validated binders are fed into secondary screens (e.g., X-ray, NMR) for binding motif analysis, could significantly improve the efficiency of fragment-based drug discovery. For proteins that do not crystallize or are not available in large amounts, this method presents an attractive alternative to X-ray crystallography and NMR.
